Mergermarket | Nelson Advisors

Nelson Advisors interviewed by Mergermarket: Electronic patient record asset owners mull exits as AI potential grows

Nelson Advisors partners Lloyd Price and Paul Hemings were interviewed by Mergermarket for their 'Electronic patient record asset owners mull exits as AI potential grows story.' Strategics and sponsors are considering exits from electronic patient record (EPR) holdings asartificial intelligence (AI) promises to disrupt the market.

Nelson Advisors

Aug 20

Nelson Advisors interviewed by Mergermarket: Big Pharma, Big Tech target genomics players to feed AI models with healthcare data

Nelson Advisors interviewed by Mergermarket: Big Pharma, Big Tech target genomics players to feed AI models with healthcare data.

Nelson Advisors

Mar 18

Add a title here. Make it bold and impactful. Click to edit.

Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.